Masahiro Natsuaki

5PUBLICATIONS
12CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 25, 2025
Aspirin vs. clopidogrel monotherapy beyond 1 month after complex percutaneous coronary intervention: a pre-specified subgroup analysis of the STOPDAPT-3 trial.

Takenori Domei, Ko Yamamoto, Masahiro Natsuaki

|Oct 24, 2024
An aspirin-free strategy for percutaneous coronary intervention in patients with diabetes: a pre-specified subgroup analysis of the STOPDAPT-3 trial.

Ko Yamamoto, Masahiro Natsuaki, Hirotoshi Watanabe

|Aug 31, 2024
Aspirin vs. clopidogrel monotherapy after percutaneous coronary intervention: 1-year follow-up of the STOPDAPT-3 trial.

Hirotoshi Watanabe, Masahiro Natsuaki, Takeshi Morimoto

|Oct 16, 2020
Ischemic and bleeding risk after complex percutaneous coronary intervention in patients with or without high bleeding risk.

Ko Yamamoto, Hiroki Shiomi, Takeshi Morimoto

|Aug 08, 2019
Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with multi-vessel coronary revascularization (from the CREDO-Kyoto PCI/CABG registry/cohort-2).

Hiroki Watanabe, Hiroki Shiomi, Takeshi Morimoto

Pageof 1